Everolimus loaded NPs with FOL targeting: preparation, characterization and study of its cytotoxicity action on MCF-7 breast cancer cell lines

Journal Title: Jordan Journal of Pharmaceutical Sciences - Year 2022, Vol 15, Issue 1

Abstract

Background and objective: The mortality cases of breast cancer (BC) are probably caused by inadequate of the benefits of treatment and early detection, moreover the lack of appropriate facilities for diagnosis and detection, also high cost effective of the treatment. The preparation of Everolimus (EV) loaded PLGA-TPGS NPs (nano-EV) targeting with folate (PLGA-TPGS-EV-FOL) and investigate their toxicity effect on human MCF-7 BC cell lines may be given an appropriate lines in BC treatment.  Methods: EV loaded NPs were prepared by combination of sonication and emulsification/solvent evaporation method with slight modifications into four formulations A, B, C , and D. EV loaded NPs were characterized by FESEM and TEM for particle size (PS) and zeta potential (ZP), FT-IR, drug loading (DL%), encapsulation efficiency (EE%), In vitro drug release, inhibition concentration IC50 and cell viability%, apoptosis, angiogenesis, glucose transporting, and HIF-1A mRNA gene expression. Results: Formulation B of EV loaded NPs was found to be lowest PS 100±12.7 nm, PDI 0.152, and have ZP, -23.2.5. The higher DL% content of EV was detected as 7.32±1.1% and EE% was 87± 2.6% in formulation B. The results suggested that the free EV dissolution was 80% within 4h but release profile of A, B, C, and D formulations within  4h were 34, 23, 26, 30%, respectively. EV formulated in NPs showed better effects against the MCF-7 BC cell line than EV free and EV loaded NPs formulation B achieved even better therapeutic effect than A, C, and D formulations. HIF-1A mRNA gene expression was decreased when treated the MCF-7 BC cells with EV loaded NPs formulation B compare to expression in untreated cells. Conclusion: EV loaded NPs may be useful in lowering the cost of treatment and may be involved in the decline of chemotherapy side effects.

Authors and Affiliations

Hamzah H. Kzar, Moaed E. Al-Gazally, Moshtak A. Wtwt

Keywords

Related Articles

Microbial Biotransformation of Some Anabolic Steroids

Microbial biotransformations of various anabolic steroids are reviewed. Studies on oxidation, reduction, and carbon bond cleavage are highlighted. Various anabolic steroid substrates, their metabolites and the microorga...

Exploring the Economic Aspects of β-Thalassemia in Jordan in 2019

Thalassemia are inherited hematological disorders considered among the most common genetic disorders worldwide, occurring more frequently in the Mediterranean Region. The WHO estimates that Beta-thalassemia affects 2.9%...

Preparation and Characterization of Hydrogel Beads for Controlled Release of Amoxicillin

Amoxicillin trihydrate-loaded hydrogel beads were prepared and characterized as a controlled drug delivery system to improve patient compliance. An ionotropic gelation process was used to prepare the hydrogel beads usin...

Acute and Sub-Acute Oral Toxicity Assessment of Mixed Extract of Trigonella Foenum-Graecum Seeds and Withania Somnifera Root in Rats

This study aimed at assessing the safety of a mixed extract of Trigonella Foenum-graecum seeds and Withania Somnifera root (TFWS), which effectively relieves male menopausal symptoms. To this end, male and female Spragu...

Molecular modeling studies of some phytoligands from Ficus sycomorus fraction as potential inhibitors of cytochrome CYP6P3 enzyme of Anopheles coluzzii

The major obstacle in controlling malaria is the mosquito’s resistance to insecticides, including pyrethroids. The resistance is mainly due to the over-expression of detoxification enzymes such as cytochromes. Insectici...

Download PDF file
  • EP ID EP711697
  • DOI -
  • Views 18
  • Downloads 0

How To Cite

Hamzah H. Kzar, Moaed E. Al-Gazally, Moshtak A. Wtwt (2022). Everolimus loaded NPs with FOL targeting: preparation, characterization and study of its cytotoxicity action on MCF-7 breast cancer cell lines. Jordan Journal of Pharmaceutical Sciences, 15(1), -. https://europub.co.uk/articles/-A-711697